Zero ad trackers.We never sell your data.Healthcare professional?Clinician Resources
Home/Rare Diseases/MCT8 Deficiency

Endocrine & Hormonal

MCT8 Deficiency (AHDS) Clinical Trials and Treatments

Also called Allan-Herndon-Dudley Syndrome, AHDS, Monocarboxylate Transporter 8 Deficiency, SLC16A2 Deficiency, MCT8-AHDS

The gene SLC16A2 makes a protein called MCT8, a transporter that carries thyroid hormone across cell membranes. It matters most at the blood-brain barrier, where it is the main route by which the active thyroid hormone T3 reaches developing nerve cells.

In plain words, MCT8 deficiency is a rare condition where thyroid hormone cannot get into the brain because the protein that carries it is broken. As a result the growing brain goes without the hormone while the rest of the body gets too much, which affects movement, learning and weight.

Get an email when new MCT8 Deficiency trials open or the FDA decides. Get alerts

MCT8 Deficiency

Where treatments stand, from ClinicalTrials.gov and FDA labels

Also 2 studies with no phase, like observational studies.

FDA review0

No decision pending. FDA calendar

FDA-approved medicines1

Emcitate

MCT8 Deficiency has 1 FDA-approved medicine, 2 open or active clinical trials (2 recruiting), and no pending FDA decision.

Labels checked October 21, 2026. Corticosteroids and immune globulins count once each.Download the data

Latest for MCT8 Deficiency

See all trialsThe week in rare disease

Each date is the day a change was posted. Open an item to see where things stand now.

More about MCT8 Deficiency

When MCT8 is missing or broken, the brain cannot take up the hormone it needs to build myelin and wire itself, and every brain scan in the 2020 natural history study showed delayed myelination.

Keep reading about MCT8 Deficiency

The developmental consequences are severe and, so far, permanent: in that study of 151 patients, the motor and cognitive abilities patients had did not improve with age, boys who had not gained head control by 18 months carried a 3.5 times higher risk of death, and 21% had died, most often of pneumonia or sudden death, with a median survival of 35 years.

The second half of the disease is the mirror image of the first. Because the brain is not taking T3 up, the hormone accumulates in the blood, and tissues that do not depend on MCT8, such as muscle, liver, heart and bone, receive far too much of it.

That produces a state doctors call peripheral thyrotoxicosis: 71% of patients in the natural history study were underweight, about a third had a resting heart rate above normal, half had raised blood pressure, and the muscle wasting and sweating families describe come from a body that cannot keep up with its own metabolism.

The blood tests are characteristic and are the fastest route to diagnosis: high T3, low or low-normal T4, and a normal or mildly raised TSH. Genetic testing of SLC16A2 confirms it.

What are the symptoms of MCT8 Deficiency?

These are common symptoms of MCT8 Deficiency, and how strong they are varies from person to person.

  • Low muscle tone (hypotonia) from the first months, with poor or absent head control
  • Severe delay in motor milestones; most affected boys never sit or walk independently
  • Severe intellectual disability with limited or no speech
  • Stiffness (spasticity) and abnormal movements (dystonia) that develop over time
  • Low body weight and difficulty gaining weight despite adequate feeding
  • Resting heart rate that is faster than normal, and heat intolerance or sweating

Who gets MCT8 Deficiency?

MCT8 deficiency is inherited on the X chromosome, so it almost always affects boys, who have only one copy of the gene. Mothers who carry the change usually have no symptoms beyond, in some cases, mild thyroid test abnormalities. Pregnancy and birth are typically uneventful and babies look healthy at first. Poor head control and low tone usually appear in the first 3 to 6 months, but because routine newborn screening measures TSH rather than T3, the diagnosis is often missed for a long time: the median age at diagnosis in the 2020 natural history study was 24 months. Girls are affected only in rare circumstances.

Next steps: find trials you might fitsee approved treatmentsget help payingget alerts

Which medicines are FDA-approved for MCT8 Deficiency?

There is currently 1 FDA-approved medication for MCT8 Deficiency.

tiratricol
Egetis Therapeutics
Search

Source: openFDA drug labeling data. This list may not include all treatments. Always consult your doctor.

How to get help paying for MCT8 Deficiency treatment

Charity funds and drugmaker programs for MCT8 Deficiency, checked at the source.

Which insurance do you have? Pick one to see what fits. Tap it again to clear.
Your insurance
Drugmaker programs
Open a medicine for who qualifies, by insurance type.

Open the full patient assistance finder →

Side effects people have reported to the FDA

Side effects people have reported to the FDA

Real-world side effect reports from the FDA Adverse Event Reporting System (FAERS). Includes both FDA-approved drugs and investigational therapies from active clinical trials. Click any drug to see what patients reported.

Loading side effect data...

Diagnosis and genetic testing

Genetic testing for MCT8 Deficiency

Genetic testing can confirm a diagnosis, guide treatment decisions, and identify family members who may be at risk.

Finding labs...

Trusted MCT8 Deficiency resources

Reputable organizations and medical references for learning more about MCT8 Deficiency, including disease registries, foundation resources, and clinical guidelines.

Active clinical trials for MCT8 Deficiency

Use this MCT8 Deficiency clinical trial finder to see the 2 studies recruiting patients in the United States and worldwide, with eligibility criteria in plain English. None of them test a treatment; they follow patients over time. Every trial comes from ClinicalTrials.gov.

Jump to the trial list, the site map or the pipeline timeline.

Note: Trial recruitment statuses on ClinicalTrials.gov may not immediately reflect recent FDA decisions, sponsor announcements, or enrollment changes. Always confirm a trial's current status directly with the study coordinator before making plans.

2 active trials worldwide
Filter:
Sort:
RecruitingPatient registry covering many conditionsRecently updatedNCT03047369

The Myelin Disorders Biorepository Project

Sponsor: Children's Hospital of Philadelphia · Biogen + 5 more

The Myelin Disorders Biorepository Project (MDBP) seeks to collect and analyze clinical data and biological samples from leukodystrophy patients worldwide to support ongoing and future research projects. The MDBP is one of the world's largest leukodystrophy biorepositories, havin...

Ages not specified
Started Dec 2016Updated yesterdayEst. Dec 2030 (~4 years)
RecruitingObservational study, no treatment givenHasn't posted an update in over a yearNCT06566066

Register for Patients With Thyroid Hormone Resistance.

Intervention: no intervention

Sponsor: Charite University, Berlin, Germany

Thyroid hormones (TH) play a pivotal role in the development and function of the mammalian brain. Patients with impaired thyroid hormone transport into the brain tissue or in the case of defective local thyroid hormone receptor (collectively referred to as thyroid hormone resista...

Ages not specified1 location
Started Jul 2021Updated 2 years agoEst. Jul 2029 (~2y 8m)
Find MCT8 Deficiency trials near you, ranked by distance →
Active trial locations22 cities in the US
A study site. Select it to see its trials and get directions. Several sites close together. Select the number to zoom in.
+14 more

Trial Pipeline

Jan 2021 to Dec 2030
2021
2023
2025
2027
2029
now
Observational
RecruitingNot yet recruitingDelayed startTodayHover a bar for trial details

Read more about MCT8 Deficiency trials

Need help understanding these trials?
Answers with sources, in plain English
Start withor ask
Run a MCT8 Deficiency foundation or patient group?
You can put this live trial list on your own website. It updates itself, and it's free.
Get the embed code →

Data from ClinicalTrials.gov, U.S. National Library of Medicine.
Always talk to your doctor before considering a clinical trial.

MCT8 Deficiency patient communities

Facebook groups, Reddit communities and YouTube channels where MCT8 Deficiency patients, caregivers and advocacy groups talk.

MCT8 Deficiency news and guides

Trial Friend articles about MCT8 Deficiency, newest first

Questions people ask about MCT8 Deficiency